Article
Minimizing false positives for CTC identification
18 Dec 2023
Abstract excerpt
Cancer is a leading cause of death worldwide, with metastasis playing a significant role. Circulating Tumour Cells (CTCs) can provide important real-time insights into tumour heterogeneity and clonal evolution, making them an important tool for early diagnosis and patient monitoring. Isolated CTCs are typically identified by immunocytochemistry using positive biomarkers (cytokeratin) and exclusion biomarkers...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
